Transcription_NN
factor_NN
GATA-1_NN
and_CC
erythroid_JJ
development_NN
._.

In_IN
summary_NN
,_,
we_PRP
derived_VBD
an_DT
experimental_JJ
system_NN
that_WDT
allows_VBZ
us_PRP
to_TO
dissect_VB
the_DT
function_NN
of_IN
GATA-1_NN
in_IN
red_JJ
cell_NN
development_NN
at_IN
a_DT
genetic_JJ
level_NN
._.

We_PRP
have_VBP
established_VBN
the_DT
essential_JJ
nature_NN
of_IN
GATA-1_NN
during_IN
both_CC
primitive_JJ
and_CC
definitive_JJ
erythropoiesis_NN
._.

By_IN
ablating_VBG
the_DT
expression_NN
of_IN
the_DT
endogenous_JJ
GATA-1_NN
gene_NN
,_,
we_PRP
are_VBP
in_IN
a_DT
position_NN
to_TO
introduce_VB
a_DT
variety_NN
of_IN
constructs_NNS
that_WDT
harbor_VBP
subtle_JJ
modifications_NNS
in_IN
flanking_JJ
or_CC
protein-coding_JJ
sequences_NNS
._.

We_PRP
can_MD
now_RB
study_VB
regulatory_JJ
regions_NNS
and_CC
functional_JJ
domains_NNS
of_IN
the_DT
protein_NN
in_IN
the_DT
context_NN
of_IN
a_DT
true_JJ
erythroid_JJ
environment_NN
,_,
experiments_NNS
that_WDT
have_VBP
not_RB
been_VBN
possible_JJ
heretofore_RB
._.

Although_IN
the_DT
assay_NN
involves_VBZ
the_DT
dramatic_JJ
loss_NN
of_IN
red_JJ
cell_NN
production_NN
,_,
it_PRP
should_MD
be_VB
possible_JJ
to_TO
define_VB
important_JJ
regulatory_JJ
domains_NNS
that_WDT
can_MD
then_RB
be_VB
assayed_VBN
using_VBG
less_RBR
stringent_JJ
systems_NNS
,_,
such_JJ
as_IN
cell-free_JJ
extracts_NNS
for_IN
in_FW
vitro_FW
transcription_NN
._.

The_DT
ideal_JJ
situation_NN
would_MD
be_VB
analyses_NNS
conducted_VBN
in_IN
GATA-1_NN
-_:
erythroid_JJ
cells_NNS
._.

However_RB
,_,
these_DT
cells_NNS
have_VBP
been_VBN
impossible_JJ
to_TO
generate_VB
given_VBN
the_DT
requirement_NN
of_IN
GATA-1_NN
for_IN
Epo_NN
receptor_NN
expression_NN
and_CC
red_JJ
cell_NN
viability_NN
-LRB-_-LRB-
C._NNP
Simon_NNP
and_CC
S._NNP
Orkin_NNP
,_,
unpublished_JJ
observations_NNS
-RRB-_-RRB-
._.

It_PRP
may_MD
be_VB
possible_JJ
to_TO
produce_VB
such_JJ
cells_NNS
by_IN
first_RB
expressing_VBG
the_DT
Epo_NN
receptor_NN
under_IN
the_DT
influence_NN
of_IN
a_DT
constitutive_JJ
promoter_NN
and_CC
then_RB
targeting_VBG
the_DT
GATA-1_NN
gene_NN
._.

If_IN
GATA-1_NN
-_:
red_JJ
cells_NNS
were_VBD
available_JJ
,_,
the_DT
analyses_NNS
would_MD
involve_VB
the_DT
actual_JJ
transcription_NN
of_IN
or_CC
chromatin_NN
structure_NN
surrounding_VBG
the_DT
globin_NN
genes_NNS
._.

Structure-function_JJ
studies_NNS
of_IN
the_DT
GATA-1_NN
protein_NN
could_MD
be_VB
greatly_RB
simplified_VBN
and_CC
a_DT
larger_JJR
number_NN
of_IN
mutants_NNS
studied_VBD
._.

However_RB
,_,
the_DT
ES_NN
cell_NN
system_NN
can_MD
be_VB
used_VBN
as_IN
an_DT
alternative_JJ
until_IN
targeted_VBN
erythroleukemia_NN
cells_NNS
become_VBP
available_JJ
._.

Other_JJ
applications_NNS
involve_VBP
the_DT
introduction_NN
of_IN
other_JJ
GATA-binding_JJ
protein_NN
family_NN
members_NNS
to_TO
determine_VB
whether_IN
they_PRP
rescue_VBP
the_DT
mutation_NN
._.

If_IN
they_PRP
can_MD
not_RB
,_,
chimeric_JJ
proteins_NNS
can_MD
be_VB
tested_VBN
to_TO
identify_VB
which_WDT
amino_NN
acids_NNS
distinguish_VBP
the_DT
different_JJ
family_NN
members_NNS
._.

We_PRP
feel_VBP
that_IN
these_DT
experiments_NNS
are_VBP
vital_JJ
to_TO
understanding_VBG
the_DT
function_NN
of_IN
GATA-1_NN
during_IN
erythroid_JJ
ontogeny_NN
._.

How_WRB
does_VBZ
GATA-1_NN
regulate_VB
red_JJ
cell_NN
genes_NNS
like_IN
globin_NN
or_CC
the_DT
Epo_NN
receptor_NN
?_.

Once_IN
we_PRP
identify_VBP
the_DT
functional_JJ
domains_NNS
of_IN
the_DT
GATA-binding_JJ
proteins_NNS
,_,
we_PRP
hope_VBP
to_TO
learn_VB
what_WP
proteins_NNS
GATA-1_NN
binds_VBZ
to_TO
in_IN
the_DT
basic_JJ
transcription_NN
machinery_NN
or_CC
in_IN
chromatin_NN
._.

Is_VBZ
GATA-1_NN
necessary_JJ
for_IN
globin_NN
gene_NN
switching_NN
?_.

GATA-1_NN
may_MD
be_VB
modified_VBN
differently_RB
during_IN
development_NN
so_RB
that_IN
the_DT
locus_NN
control_NN
region_NN
can_MD
interact_VB
with_IN
different_JJ
globin_NN
promoters_NNS
._.

We_PRP
may_MD
find_VB
that_IN
one_CD
region_NN
of_IN
the_DT
protein_NN
is_VBZ
required_VBN
for_IN
embryonic_JJ
expression_NN
and_CC
another_DT
for_IN
adult_JJ
globin_NN
gene_NN
expression_NN
._.

